Revolve Wealth Partners, LLC Bristol Myers Squibb CO Transaction History

Revolve Wealth Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	BUY	$63.71 - $70.74 $48,037 - $53,337	754 Added 24.88%	3,785 $242,000
Q1 2023 Apr 06, 2023	SELL	$65.71 - $74.53 $41,660 - $47,252	-634 Reduced 17.3%	3,031 $210,000
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $52,866 - $62,601	772 Added 26.69%	3,665 $0
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $1 - $922	-12 Reduced 0.41%	2,893 $206,000
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $3,267 - $3,599	-45 Reduced 1.53%	2,905 $224,000
Q1 2022 Apr 19, 2022	SELL	$61.48 - $73.72 $23,792 - $28,529	-387 Reduced 11.6%	2,950 $215,000
Q4 2021 Feb 04, 2022	BUY	$53.63 - $62.52 $178,963 - $208,629	3,337 New	3,337 $208,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Revolve Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Revolve Wealth Partners, LLC with notifications on news.